| Trial ID: | L0885 |
| Source ID: | NCT02032095
|
| Associated Drug: |
Gb-0998
|
| Title: |
The Desensitization Therapy With GB-0998 for Anti-donor Antibody-positive Recipients.
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
End Stage Renal Disease
|
| Interventions: |
DRUG: GB-0998
|
| Outcome Measures: |
Primary: Negative rate of FCXM-T after the fourth administration of GB-0998, at 4 weeks |
|
| Sponsor/Collaborators: |
Sponsor: Japan Blood Products Organization
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2|PHASE3
|
| Enrollment: |
17
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2013-11
|
| Completion Date: |
2015-09
|
| Results First Posted: |
|
| Last Update Posted: |
2016-02-05
|
| Locations: |
Japan Blood Products Organization, Tokyo, Japan
|
| URL: |
https://clinicaltrials.gov/show/NCT02032095
|
